Clinical Trial Update: Assessment of Midodrine in the Prevention of Vasovagal Syncope: The Prevention of Syncope Trial IV [Phase 4]

View source ↗

Summary

An update on the Phase 4 Prevention of Syncope Trial IV evaluating midodrine for preventing vasovagal syncope; the study is currently active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Vasovagal Syncope

Drugs mentioned

• Midodrine (Midodrine)

Snippet

Sponsor: Dr. Bob Sheldon | Conditions: Vasovagal Syncope | Phase 4 | Status: ACTIVE_NOT_RECRUITING